Related Experiment Videos
[Percutaneous lung cancer cryotherapy guided by computer tomography]
Hong-wu Wang1, Yan-qun Zhang, Jing Luo
1Tumor Cryotherapy Center, Navy General Hospital, People's Liberation Army, Beijing 100037, China.
Summary
Computer Tomography (CT)-guided percutaneous lung cancer cryotherapy (PLC) is a safe and effective treatment. This minimally invasive procedure shows promise for lung neoplasms across all stages and locations.
Area of Science:
- Oncology
- Interventional Radiology
Background:
- Lung cancer remains a leading cause of cancer-related mortality worldwide.
- Minimally invasive treatment options are crucial for managing lung neoplasms, especially in patients with advanced disease or comorbidities.
Purpose of the Study:
- To evaluate the feasibility, safety, and efficacy of Computer Tomography (CT)-guided percutaneous lung cancer cryotherapy (PLC).
Main Methods:
- A total of 237 patients with lung cancer underwent CT-guided PLC between August 2001 and April 2003.
- Feasibility and safety were assessed, with immediate ice formation visualized by CT.
- Tumor response, side effects, and survival rates were monitored post-cryoablation.
Main Results:
- PLC was feasible and safe under local anesthesia, with minimal side effects and no deaths.
- Effective ice coverage was achieved, with tumor size influencing coverage rates.
- CT scans showed tumor necrosis in 78% of cases, with good long-term survival rates for early-stage patients.
Conclusions:
- CT-guided PLC is a promising, minimally invasive treatment for lung neoplasms.
- The procedure is associated with low morbidity and can be applied to tumors at various stages and locations.
- Further research can explore its role in multimodal lung cancer therapy.